EnteroBiotix · £19M · Series Unknown

EnteroBiotix has secured £19 million in funding to support a clinical trial for microbiome-based therapies targeting irritable bowel syndrome. The company is based in Glasgow.

AI-generated: summaries written by AI from the linked sources. How we use AI